Evidence from the aged orchidectomized male rat model that 17β-estradiol is a more effective bone-sparing and anabolic agent than 5α-dihydrotestosterone

Journal of Bone and Mineral Research

Volumn 17, Issue 11, 2002, Pages 2080-2086

  Vandenput, L ^a   Boonen, S ^b   Van Herck, E ^a   Swinnen, J V ^a   Bouillon, R ^a   Vanderschueren, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Androgens; Bone; Estrogens; Fat mass; Lean body mass; Orchidectomy

Indexed keywords

ANDROSTANOLONE; ESTRADIOL;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE TURNOVER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HORMONE ACTION; LEAN BODY WEIGHT; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; ORCHIECTOMY; OSTEOLYSIS; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; SEMINAL VESICLE; TRABECULAR BONE;

EID: 0036829959     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.11.2080     Document Type: Article

References (29)

1. Vermeulen A 2001 Androgen replacement therapy in the aging male - A critical evaluation. J Clin Endocrinol Metab 86:2380-2390.
2. Riggs BL, Khosla S, Melton LJ III 1998 A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763-773.
3. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL 1999 Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966-1972.
4. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL 1999 Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653.
5. Tenover JL 1992 Effect of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092-1098.
6. Wakley GK, Schutte HD, Hannon KS, Turner RT 1991 Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res 6:325-330.
7. Vanderschueren D, Van Herck E, Suiker AMH, Visser WJ, Schot LPC, Bouillon R 1992 Bone and mineral metabolism in aged male rats: Short and long term effects of androgen deficiency. Endocrinology 130:2906-2916.
8. Vanderschueren D, Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R 2000 An aged rat model of partial androgen deficiency: Prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology 141:1642-1647.
9. Verhaeghe J, Van Herck E, Van Bree R, Van Assche FA, Bouillon R 1989 Osteocalcin during the reproductive cycle in normal and diabetic rats. J Endocrinol 120:143-151.
10. Verhaeghe J, Van Herck E, Visser WJ, Suiker AMH, Thomasset M, Einhorn TA, Faierman E, Bouillon R 1990 Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39:477-482.
11. Vermeulen A, Verdonck L 1976 Radioimmunoassay of 17β-hydroxy-5α-androstan-3-one, 4-androstene-3,17-dione, dehydroepiandrosterone, 17-hydroxyprogesterone, and progesterone and its application to human male plasma. J Steroid Biochem 7:1-10.
12. Vanderschueren D, Jans I, Van Herck E, Moermans K, Verhaeghe J, Bouillon R 1994 Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. Bone Miner 26:123-131.
13. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ 2001 A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86:4078-4088.
14. Frost HM 1987 The mechanostat: A proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 2:73-85.
15. Yao W, Jee WSS, Chen J, Liu H, Tam CS, Cui L, Zhou H, Setterberg RB, Frost HM 2000 Making rats rise to erect bipedal stance for feeding partially prevented orchidectomy-induced bone loss and added bone to intact rats. J Bone Miner Res 15:1158-1168.
16. Boonen S, Cheng XG, Nijs J, Nicholson PHF, Verbeke G, Lesaffre E, Aerssens J, Dequeker J 1997 Factors associated with cortical and trabecular bone loss as quantified by peripheral quantitative computed tomography. Calcif Tissue Int 60:164-170.
17. Simpson ER 1998 Genetic mutations resulting in estrogen insufficiency in the male. Mol Cell Endocrinol 145:55-59.
18. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson J-A, Ohlsson C 2000 Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 97:5474-5479.
19. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560.
20. Miyaura C, Toda K, Inada M, Ohshiba T, Matsumoto C, Okada T, Ito M, Shizuta Y, Ito A 2001 Sex- and age-related response to aromatase deficiency in bone. Biochem Biophys Res Commun 280:1062-1068.
21. Ke HZ, Qi H, Crawford DT, Chidsey-Frink KL, Simmons HA, Thompson DD 2000 Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat. Endocrinology 141:1338-1344.
22. Ke HZ, Qi H, Chidsey-Frink KL, Crawford DT, Thompson DD 2001 Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats. J Bone Miner Res 16:765-773.
23. Taxel P, Albertsen P, Fall P, Kennedy D, Trahiotis M, Raisz LG 2000 Estrogen decreases bone resorption in older men receiving hormonal suppression for prostate cancer. J Bone Miner Res 15:S1;S223 (abstract).
24. Compston JE 2001 Sex steroids and bone. Physiol Rev 81:419-447.
25. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS 2000 Increased adipose tissue in male and female estrogen receptor - A knockout mice. Proc Natl Acad Sci USA 97:12729-12734.
26. Jones MEE, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735-12740.
27. Vanderschueren D, Boonen S, Ederveen AGH, De Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A, Bouillon R 2000 Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone 27:611-617.
28. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207.
29. Vanderschueren D, Boonen S, Bouillon R 1998 Action of androgens versus estrogens in male skeletal homeostasis. Bone 23:391-394.